"A new imaging modality to non-invasively assess multiple sclerosis pathology"

Area of Science:

• Neuroimaging
• Biomedical Engineering
• Neurology

Background:

• Diffusion Tensor Imaging (DTI) is commonly used for assessing axon pathology and demyelination.
• DTI may yield false interpretations in acute inflammation and chronic tissue loss, common in multiple sclerosis.
• A need exists for more accurate imaging techniques in complex neurological conditions.

Purpose of the Study:

• Introduce Diffusion Basis Spectrum Imaging (DBSI) as a novel method for central nervous system (CNS) pathology assessment.
• To differentiate between isotropic and anisotropic diffusion components for improved diagnostic accuracy.
• To provide more reliable measures of axon and myelin integrity in CNS disorders.

Main Methods:

• DBSI computationally separates isotropic and anisotropic diffusion signals within imaging voxels.
• Isotropic diffusion is analyzed for inflammatory components (edema, cells) and intrinsic tissue characteristics.
• Anisotropic diffusion components are used to measure axial diffusivity (axon integrity) and radial diffusivity (myelin integrity).

Main Results:

• DBSI provides a more nuanced understanding of tissue microstructure compared to DTI.
• The method distinguishes inflammatory changes from structural damage.
• Accurate measurements of axon and myelin integrity are achievable even in complex pathologies.

Conclusions:

• DBSI represents a significant advancement in neuroimaging for CNS pathology.
• This technique enhances diagnostic capabilities for conditions like multiple sclerosis.
• DBSI offers a more robust tool for evaluating neurological disease progression and treatment response.